겨울 심포지움
2018겨울초록
발표자 및 발표 내용
소속 |
|
---|---|
발표구분 |
|
구두발표 | |
포스터발표 |
|
Keyword |
주저자
이름 |
|
---|---|
소속 |
|
국가 |
|
공동저자
공동저자 |
|
---|
접수자
이름 |
|
---|---|
소속 |
|
We demonstrate an improved MALDI-TOF MS-based beta-lactamase assay platform for cefotaxime, a representative third-generation cephalosporins, resistant bacteria. Cefotaxime that was incubated with the lysates of E. coli exhibiting extended-spectrum beta-lactamase (ESBL) activity was modified by Girard’s reagent T to introduce permanent positive charge at the carboxyl functional groups of cefotaxime, resulting in dramatic advances on the ionization efficiency and quantitativeness during MS analysis. The method was validated with clinical isolates of a variety of ESBL-producing E. coli. In comparison with conventional UPLC system, it showed reliable data for distinguishing cefotaxime-resistant bacteria. This improved MS-based beta-lactamase activity assay platform would be utilized to more rapidly and accurately detect clinically relevant antibiotic resistant bacteria in clinical settings.
게시물수정
게시물 수정을 위해 비밀번호를 입력해주세요.
댓글삭제게시물삭제
게시물 삭제를 위해 비밀번호를 입력해주세요.